Article
Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association - 1 Dec 2005
Klemm T, Mehnert A K, Siegemund A, Wiesner T D, Gelbrich G, Blüher M, Paschke R
Abstract excerpt
A Thr789Ala variant in the von Willebrand Factor (vWF) gene is associated with increased vWF plasma concentrations and might therefore affect the risk of coronary heart disease (CHD) in the general population. Patients with type 2 diabetes have an increased risk for premature atherosclerosis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.